Journal of Clinical Oncology (JCO) Podcast

View Top 200 Chart

Back to Rankings Page

Health & Fitness
**Journal of Clinical Oncology (JCO) Podcast**

The Journal of Clinical Oncology Podcast presents analyses and discussions centered on the latest findings published in ASCO’s flagship Journal of Clinical Oncology. Host Dr. Davide Soldato facilitates interviews and scholarly discourse on the most impactful published findings. The Journal of Clinical Oncology Podcast is the trusted resource that empowers you to integrate cutting-edge evidence into clinical practice.

The year’s fellows interview authors and summarize the top Journal of Clinical Oncology articles in the series, JCO Article Insights.

Latest Episodes:

Breast Cancer and Weight Loss: Where Do We Go from Here? Aug 17, 2015

Show notes

The Promise and the Pitfalls of Population-Wide Screening of BRCA1 and BRCA2 Aug 17, 2015

Show notes

Intraperitoneal Therapy for Ovarian Cancer: No More Excuses Aug 06, 2015

Show notes

This podcast will examine data on utilization, toxicity and survival outcomes with the use of intraperitoneal chemotherapy for initial treatment of ovarian cancer at six NCCN institutions.

Balancing Safety and Efficacy in the Treatment Hodgkin Lymphoma: Early Discontinuation of Certain Drugs Can and Should Be Done Jun 22, 2015

Show notes

Analogous to prior analyses with ABVD, in a large series of Hodgkin lymphoma patients treated with BEACOPP, Haverkamp and colleagues from the German Hodgkin Study Group report that early discontinuation of bleomycin or vincristine due to toxicity has no impact on cure rates or survival.

When Toxicity and Efficacy Collide Jun 08, 2015

Show notes

This podcast explores the complicated relationship between potency, toxicity, and duration of therapy, and how each impacts the overall efficacy of therapy.

First Results of Euramos I and Logistics of International Collaboration for Clinical Trials of Rare Diseases Jun 01, 2015

Show notes

This study involved working together across oceans, regulatory bodies in various countries, different cultures in 4 cooperative groups, different standard chemotherapy administration guidelines, and putting aside personal biases and styles to work together and come up with a document acceptable to all, in order to conduct an international trial in a rare disease for the benefit of children with osteosarcoma.

Treatment Advances in Local-Regionally Advanced and Stage IVB/Recurrent Cervical Cancer: Can We Agree that More Isn't Always Better? May 18, 2015

Show notes

The two recent papers by Kitagawa, et al and Rose, et al, give us treatment options and tools that help maximize not only the benefits of survival with treatment but minimization of non-beneficial treatment toxicity through identification of patients with advanced and recurrent cervical cancer that are most and least likely to benefit.

Androgen Deprivation Therapy for Prostate Cancer - Friend or Foe to the Psyche? May 11, 2015

Show notes

This is a well-annotated study demonstrating that men treated with androgen deprivation therapy for prostate cancer have impaired cognitive performance within six months of starting therapy and that a specific genetic polymorphism may lend toward greater susceptibility to cognitive impairment.

Building Blocks in the Case for Adjuvant Therapy in Biliary Tract Cancers May 11, 2015

Show notes

This podcast places the results of SWOG S0809, a phase II intergroup trial of adjuvant capecitabine/gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma, in context with prior conflicting data and discusses implications for development of a definitive phase III trial.

Aromatase Inhibitor Arthralgias: Identification, Treatment Options and Research Perspectives May 04, 2015

Show notes

This is a requested commentary regarding a concurrently-published manuscript which evaluated the utility of omega-2 fatty acids for the treatment of aromatase inhibitor-associated arthralgias.